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Introduction
Empiric broad-spectrum antibiotic treatment for ortho-
paedic implant infections after surgical lavage is com-
mon practice while awaiting microbiological results, but
lacks evidence.
Objectives
Our objective was to question the indication of broad-
spectrum empiric therapy in this clinical setting.
Methods
Single-centre cohort study conducted from 1996 to
2011. Methicillin-resistant Staphylococcus aureus ende-
micity ranged from 23-32% among clinical S. aureus iso-
lates throughout the study period. Bacteremic cases
were excluded.
Results
We retrieved 342 implant infections and followed them
for a median of 3.5 years (61 recurred; 18%). Infected
implants were arthroplasties (n=186), different plates,
nails, or other osteosyntheses. Main pathogens were S.
aureus (163; 49 methicillin-resistant) and coagulase-
negative staphylococci (60; 45 methicillin-resistant).
Median duration of empiric antibiotic coverage after
surgical drainage was 3 days before switching to targeted
therapy. Vancomycin was the most frequently used
initial empiric agent (147), followed by intravenous co-
amoxiclav (44). Most empiric antibiotic regimens (269;
79%) proved sensitive to the causative pathogen, but
were too broad in 111 episodes (32%). Although they
would have covered 59% of later identified causative
pathogens, cephalosporins and penicillins were used
only in 44 and 10 cases, respectively. Empiric anaerobic
coverage was given in 130 episodes (38%), although only
five co-pathogens were anaerobes. Multivariate Cox
regression analysis showed that neither susceptible anti-
biotic coverage (compared to non-susceptible; hazard
ratio, 0.7, 95% CI, 0.4-1.2) nor exaggerated broad-spec-
trum use (hazard ratio, 1.1, 0.8-1.5) changed remission
rates.
Conclusion
Provided that surgical drainage is performed, broad-
spectrum antibiotic coverage during the first 3 days
does not enhance remission of orthopaedic implant
infections. If empiric agents are prescribed from the first
day of infection, narrow-spectrum penicillins or cepha-
losporins can be considered to avoid unnecessary broad-
spectrum and anti-anaerobic antibiotic use. Randomized
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